(Q84476713)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20578180%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

title

Characteristics of patients with stage III colon adenocarcinoma who fail to receive guideline-recommended treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20578180%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

Marcy Winget

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20578180%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Shakhawat Hossain

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20578180%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Yutaka Yasui

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20578180%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Andrew Scarfe

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20578180%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

publication date

1 October 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20578180%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20578180%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

volume

116

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20578180%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

issue

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20578180%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

page(s)

4849-4856

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20578180%20AND%20SRC:MED&resulttype=core&format=json

Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma

6 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25250

7 January 2021

Adjuvant chemotherapy for stage III colon cancer: implications of race/ethnicity, age, and differentiation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25250

7 January 2021

Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25250

7 January 2021

Age and adjuvant chemotherapy use after surgery for stage III colon cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25250

7 January 2021

Age, sex, and racial differences in the use of standard adjuvant therapy for colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25250

7 January 2021

Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25250

7 January 2021

Comparison of treatment received versus long-standing guidelines for stage III colon and stage II/III rectal cancer patients diagnosed in Alberta, Saskatchewan, and Manitoba in 2004.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25250

7 January 2021

Palliative radiotherapy for women with breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25250

7 January 2021

Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25250

7 January 2021

Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25250

7 January 2021

Across-province standardization and comparative analysis of time-to-care intervals for cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25250

7 January 2021

Approaches for estimating prevalence ratios

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25250

7 January 2021

Social and Economic Factors in the Choice of Lung Cancer Treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25250

7 January 2021

Impact of deprivation and rural residence on treatment of colorectal and lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25250

7 January 2021

Referral to medical oncology: a crucial step in the treatment of older patients with stage III colon cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25250

7 January 2021

A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25250

7 January 2021

Comorbidity and functional status are independent in older cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25250

7 January 2021

Patient age and cancer treatment decisions. Patient and physician views

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25250

7 January 2021

Cancer treatment and age: patient perspectives

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25250

7 January 2021

Age and clinical decision making in oncology patients.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25250

7 January 2021

Identifiers

DOI

10.1002/CNCR.25250

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20578180%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference